| Acquired by | Entelos |
| Price | $39.1M |
| Date | 8/07 |
| Terms | Stock |
| Website | iconixbiosciences... |
| Category | BioTech |
| Employees | |
| Description | Pharmacology Database and analysis |
| TOTAL | $4M |
| FUNDING TOTAL | $4M |
| Venture Round, 1/07 | $4M |
Iconix Biosciences provides a toxicogenomics database of microarray and pharmacology data (DrugMatrix®) with the informatics expertise and computer skills required to mine and interpret this vast body of information.
Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures®, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action.